Biotechnology Stocks
| # | 7 Derniers Jours | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4555 |  AEON AEON Biopharma, Inc. Class A Common Stock | 0.31 USD | 0.00% | +3.33% | +3.33% | -70.19% | 15.46 M USD | ||
| 4559 |  ICU SeaStar Medical Holding Corporation - Common Stock | 3.49 USD | -6.18% | -7.67% | +12.94% | +41.87% | 15.38 M USD | ||
| 4568 |  NCEL NewcelX Ltd. - Ordinary Shares | 3.11 USD | +2.30% | +9.89% | -5.47% | -38.78% | 14.92 M USD | ||
| 4571 |  KTTA Pasithea Therapeutics Corp. - Common Stock | 0.44 USD | 0.00% | -6.38% | -22.81% | -43.59% | 14.70 M USD | ||
| 4573 |  TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 USD | -17.86% | -30.30% | -28.13% | -89.55% | 14.61 M USD | ||
| 4576 |  TVRD Tvardi Therapeutics, Inc. - Common Stock | 1.08 USD | -1.82% | -13.60% | -40.98% | -70.00% | 14.41 M USD | ||
| 4577 |  KZIA Kazia Therapeutics Limited - American Depositary Shares | 8.82 USD | -5.06% | -8.03% | -24.94% | +50.77% | 14.28 M USD | ||
| 4579 |  HIND Vyome Holdings, Inc. - Common Stock | 2.03 USD | -0.49% | +10.33% | -3.33% | -63.81% | 14.25 M USD | ||
| 4588 |  KPTI Karyopharm Therapeutics Inc. - Common Stock | 0.60 USD | -7.69% | -30.23% | -64.29% | -93.78% | 13.61 M USD | ||
| 4589 |  INAB IN8bio, Inc. - Common Stock | 1.38 USD | -1.43% | -2.82% | +27.78% | -17.37% | 13.60 M USD | ||
| 4590 |  RADX Radiopharm Theranostics Limited American Depositary Shares | 1.15 USD | -2.54% | -20.14% | -45.50% | -84.38% | 13.59 M USD | ||
| 4592 |  CTXR Citius Pharmaceuticals, Inc. - Common Stock | 0.49 USD | -2.00% | -9.26% | -18.33% | -62.60% | 13.45 M USD | ||
| 4596 |  CLRB Cellectar Biosciences, Inc. - Common Stock | 1.40 USD | -7.28% | -28.21% | -40.43% | -55.41% | 13.23 M USD | ||
| 4620 |  PLUR Pluri Inc. - Common Stock | 1.00 USD | -3.85% | -3.85% | -25.37% | -73.82% | 12.34 M USD | ||
| 4626 |  INTS Intensity Therapeutics, Inc. - Common Stock | 3.68 USD | -3.16% | +12.54% | -8.91% | +894.59% | 12.01 M USD | ||
| 4627 |  PASG Passage Bio, Inc. - Common Stock | 3.73 USD | -3.37% | -12.85% | -25.25% | -57.81% | 12.00 M USD | ||
| 4631 |  DARE Dare Bioscience, Inc. - Common Stock | 0.77 USD | -2.53% | -11.49% | +10.00% | -53.33% | 11.77 M USD | ||
| 4635 |  ASBP Aspire Biopharma Holdings, Inc. - Common Stock | 8.30 USD | -3.82% | -0.84% | +1.10% | +432.05% | 11.64 M USD | ||
| 4641 |  PHIO Phio Pharmaceuticals Corp. - Common Stock | 0.99 USD | -1.00% | -1.98% | -3.88% | -16.81% | 11.50 M USD | ||
| 4645 |  TPST Tempest Therapeutics, Inc. - Common Stock | 0.77 USD | -2.53% | -6.10% | -18.09% | -67.78% | 11.40 M USD |
Nouvelles Biotechnology Stocks
Le médicament de Pharvaris contre l’angiœdème héréditaire soulage plus vite
Raymond James initie une couverture de Kymera Therapeutics avec une note de surperformance
Raymond James initie la couverture de Nektar avec une note Performance Marché
L’action Palisade Bio initiée à Surperformance par Raymond James
Raymond James réitère sa note sur l’action Liquidia malgré les dépôts juridiques
Tenax Therapeutics suspend temporairement le recrutement dans l’essai LEVEL-2 de TNX-103 afin de modifier les critères ; demande une réunion avec la FDA
Ginkgo Bioworks soutient le programme NSF X-Labs avec son laboratoire
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |